Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription 01.06.2026 2 Am J Hematol 1 Biochem Biophys Res Commun 1 Blood 1 BMC Cancer 1 Bone Marrow Transplant 2 Br J Haematol 4 Haematologica 2 J Am Acad Dermatol 1 J Biol Chem 1 Leuk Lymphoma 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. GAO J, Lyu LW, Wang L
   Response to: "Refining Combined-Modality Therapy and Charting the Future of Primary Vitreoretinal Lymphoma".
   Am J Hematol. 2026 May 26. doi: 10.1002/ajh.70385.
   PubMed        
   
   
2. TRABOLSI A, Lossos IS
   Response to: "Refining Combined-Modality Therapy and Charting the Future of Primary Vitreoretinal Lymphoma".
   Am J Hematol. 2026 May 23. doi: 10.1002/ajh.70380.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

3. YU L, Wu S, Li L, Yang J, et al
   BCL2L10 Is a non-GCB-associated prognostic biomarker and functional driver in diffuse large B-Cell lymphoma.
   Biochem Biophys Res Commun. 2026;827:154000.
   PubMed         Abstract available
   
   

   
   Blood

4. GOBEL C, Niccolai R, Gregoricchio S, de Groot MHP, et al
   DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma.
   Blood. 2026 May 29:blood.2025031615. doi: 10.1182/blood.2025031615.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. SHI J, Lu C, Song C, Wang Q, et al
   Efficacy and safety of CD30-targeted chimeric antigen receptor T-cell therapy for lymphoma: a meta-analysis.
   BMC Cancer. 2026 May 25. doi: 10.1186/s12885-026-16121.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

6. DADA R, Apostolidis J, Ibrahim RB, Salem AA, et al
   Role of consolidative radiotherapy in preventing relapses and subsequent salvage ASCT in early-stage classic Hodgkin lymphoma.
   Bone Marrow Transplant. 2026 May 28. doi: 10.1038/s41409-026-02921.
   PubMed         Abstract available
   
   

   
   Br J Haematol

7. FRUTOS DIAZ-ALEJO J, Diaz de la Pinta FJ, Pavia Pascual L, Manso R, et al
   DNMT3A variants are associated with the development of nodal TFH cell lymphoma, angioimmunoblastic-type after solid tumour occurrence.
   Br J Haematol. 2026 May 24. doi: 10.1111/bjh.70576.
   PubMed        
   
   
8. CHENG Q, Zhu Y, Sheng K, Zhou J, et al
   Long-term outcomes after allogeneic versus autologous haematopoietic stem cell transplantation for T-lymphoblastic lymphoma.
   Br J Haematol. 2026 May 24. doi: 10.1111/bjh.70581.
   PubMed         Abstract available
   
   

   
   Haematologica

9. LAZAROVICI J, Amorim S, Bouabdallah K, Fournier M, et al
   Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study.
   Haematologica. 2026 May 28. doi: 10.3324/haematol.2025.300166.
   PubMed         Abstract available
   
   
10. DANN EJ
    Response to Comment on: "Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?".
    Haematologica. 2026 May 28. doi: 10.3324/haematol.2026.301249.
    PubMed         Abstract available
    
    
11. THARMASEELAN H, Von Tresckow B
    On closing the gap: anti-PD-1-based salvage in relapsed/refractory classical Hodgkin lymphoma. Comment on: "Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma".
    Haematologica. 2026 May 28. doi: 10.3324/haematol.2026.301234.
    PubMed         Abstract available
    
    
12. BOUSSI L, Ovalle NT, Imber BS, Ewalt MD, et al
    Lorlatinib-induced remission in refractory acute myeloid leukemia with an anaplastic lymphoma kinase fusion.
    Haematologica. 2026 May 28. doi: 10.3324/haematol.2026.300893.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

13. SUHL S, Zhou MH, Kaminsky A, Kent J, et al
    Staging imaging reveals clinically significant comorbidities in primary cutaneous marginal zone lymphoma: A retrospective study.
    J Am Acad Dermatol. 2026 May 25:S0190-9622(26)02738.
    PubMed        
    
    
14. HOLM J, Ostroff E, Clarke LP, De Jong K, et al
    Cutaneous T-cell lymphoma tumors undergoing radiotherapy demonstrate immune shifts from malignant inflammation to wound healing and suggest markers of treatment durability.
    J Am Acad Dermatol. 2026 May 25:S0190-9622(26)02766.
    PubMed        
    
    

    
    J Biol Chem

15. JAVADEKAR SM, Das S, Hanumegowda SM, Kumari S, et al
    Canonical and noncanonical forms of G4 DNA at cluster III of the BCL6 breakpoint region could lead to chromosomal translocation in DLBCL.
    J Biol Chem. 2026;302:111347.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

16. LOH Z, Chung E, Wellard C, Opat S, et al
    Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study.
    Leuk Lymphoma. 2026 May 26:1-9. doi: 10.1080/10428194.2026.2673099.
    PubMed         Abstract available
    
    

    
    PLoS One

17. JIANG W, Liu P
    Comparison of dose-adjusted EPOCH-R and R-CHOP in diffuse large B-cell lymphoma with high Ki67 expression: Results from a prospective observational study.
    PLoS One. 2026;21:e0350024.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

18. WANG C, Bristol JA, Nelson SE, Chen T, et al
    Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression.
    Proc Natl Acad Sci U S A. 2026;123:e2525164123.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

19. BURLILE JF, Harmsen WS, Suddendorf SD, Frechette KM, et al
    Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions.
    Radiother Oncol. 2026;219:111515.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum